Cliff Asness’s Avadel Pharmaceuticals AVDL Stock Holding History

Cliff Asness’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,963	Closed	-$430K	–	3748
2025 Q4	$430K	Sell	19,963 -48,119	-71%	-$934K	﹤0.01%	2992
2025 Q3	$1.04M	Buy	68,082 +32,461	+91%	+$422K	﹤0.01%	2413
2025 Q2	$315K	Buy	+35,621	New	+$313K	﹤0.01%	2848

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cliff Asness's AVDL Position: Q1 2026 in Review

Cliff Asness sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 19,963 shares — an estimated $430K sold.

Cliff Asness first reported a position in AVDL in Q2 2025 and held it in 3 quarters. The position peaked at $1.04M in Q3 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Cliff Asness reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Cliff Asness sold 19,963 Avadel Pharmaceuticals shares in Q1 2026, an estimated $430K.
Cliff Asness first reported a position in Avadel Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Cliff Asness's Avadel Pharmaceuticals position peaked at $1.04M in Q3 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.